Provided by Tiger Trade Technology Pte. Ltd.

Immunovant, Inc.

26.60
+0.24000.91%
Volume:719.67K
Turnover:19.03M
Market Cap:5.41B
PE:-9.93
High:26.78
Open:26.17
Low:25.76
Close:26.36
52wk High:27.92
52wk Low:12.72
Shares:203.53M
Float Shares:89.02M
Volume Ratio:0.70
T/O Rate:0.81%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.6799
EPS(LYR):-2.7303
ROE:-69.35%
ROA:-41.33%
PB:5.49
PE(LYR):-9.74

Loading ...

Jun 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 29, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
May 29, 2025

Major Issues Report

Form 8-K - Current report
May 22, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 01, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Apr 21, 2025

Major Issues Report

Form 8-K - Current report
Mar 19, 2025

Major Issues Report

Form 8-K - Current report
Mar 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 14, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 11, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 06, 2025

Major Issues Report

Form 8-K - Current report
Feb 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jan 24, 2025

Major Issues Report

Form 8-K - Current report
Jan 14, 2025

Major Issues Report

Form 8-K - Current report
Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Dec 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 07, 2024

Major Issues Report

Form 8-K - Current report